Intended for healthcare professionals

Editor's Choice

Minimum alcohol pricing: a shameful episode

BMJ 2014; 348 doi: (Published 08 January 2014) Cite this as: BMJ 2014;348:g110

This article has a correction. Please see:

  1. Fiona Godlee, editor, BMJ
  1. fgodlee{at}

This time last year public health campaigners and policy makers were confident that a minimum price on a unit of alcohol would be introduced across the United Kingdom. The evidence for substantial health benefits and cost savings was clear, a public consultation on the level of the price was just closing, Scotland had introduced a minimum unit price (though now under legal challenge by the drinks industry), and the UK prime minister had given his personal commitment that England and Wales would follow suit. Then in July the government announced that the policy had been shelved.

The politics behind this sudden U-turn have been something of a mystery. The Home Office minister Jeremy Browne gave as his reason that the government didn’t have “enough concrete evidence” that a minimum price would reduce the harms of problem drinking without penalising responsible drinkers on low incomes. However, as Jonathan Gornall has discovered in a BMJ investigation published this week (doi:10.1136/bmj.f7435, doi:10.1136/bmj.f7531, doi:10.1136/bmj.f7571, doi:10.1136/bmj.f7610, doi:10.1136/bmj.f7629), the government had the necessary evidence, in the form of a report commissioned by the government in 2008. But in an agreement between the Home Office and the report’s academic authors it was embargoed until after Browne’s announcement.

This sleight of hand by ministers has shocked even experienced public health campaigners, including our editorialists Ian Gilmore and Mike Daube (doi:10.1136/bmj.g23). More shocking still are Gornall’s findings of the extent and effects of contact between ministers and interest groups lobbying against the minimum unit price. Requests made under freedom of information legislation have revealed dozens of face to face meetings between senior ministers and industry representatives, during and after the public consultation, leading Gornall to conclude that the consultation itself was a sham.

Carefully nurtured long term relationships have led to what one academic calls “quite astonishing levels of contact.” While MPs struggled to gain access to ministers, representatives of alcohol companies and major supermarkets had easy access—made easier by the well oiled “revolving door” between industry and special advisory posts. The lobbying was backed up by reports from think tanks linked to the industry that seeded cleverly targeted doubts about the evidence, using tactics reminiscent of the tobacco industry. Academics quoted by Gornall express concern about misuse of the scientific process by the alcohol industry and its mouthpieces.

The industry undoubtedly delivers benefits to society in employment and tax revenues and in the pleasures and even health benefits of moderate alcohol consumption. But as Nick Sheron and Kate Eisenstein explain in a commentary (doi:10.1136/bmj.g67), the costs of harm caused by problem drinking far outweigh alcohol’s revenues. The effect of heavy drinking of cheap alcohol in deprived communities is “savage,” they say, and tax payers are bearing the cost. Meanwhile the highly targeted minimum unit price would have almost no impact on low risk drinkers. “Taking the cheapest booze out of the system is just about the perfect alcohol policy,” they say.

Gornall’s extensive investigation, published in full at, shows beyond doubt that commercial interests are currently in control of key decisions about the public’s health. As the GP and Conservative MP Sarah Wollaston told Gornall, “You’ve got a government telling doctors to get out there and reduce avoidable mortality and yet they’ve stepped away from one of the best tools they could deliver for doctors to be able to do that.” It is, as she says, outrageous.


Cite this as: BMJ 2014;348:g110


View Abstract